Y-Biologics, Inc. (KOSDAQ:338840)
South Korea · Delayed Price · Currency is KRW 25,600
-350 (-1.35%)
At close: Feb 27, 2026
Y-Biologics Market Cap
Y-Biologics has a market cap or net worth of 388.56 billion as of February 27, 2026. Its market cap has increased by 272.31% in one year.
Market Cap
388.56B
Enterprise Value
365.43B
Revenue
3.61B
Ranking
n/a
PE Ratio
n/a
Stock Price
25,600.00
Market Cap Chart
Since December 5, 2023, Y-Biologics's market cap has increased from 177.50B to 388.56B, an increase of 118.91%. That is a compound annual growth rate of 42.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 388.56B | 11.79% |
| Dec 30, 2025 | 347.58B | 205.76% |
| Dec 30, 2024 | 113.68B | -50.64% |
| Dec 28, 2023 | 230.30B | 29.75% |
| Dec 5, 2023 | 177.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HansBiomed | 692.96B |
| S.Biomedics | 474.97B |
| curacle co.,ltd. | 369.39B |
| NIBEC | 352.91B |
| ABION | 288.32B |
| Bio Solution | 226.01B |
| Genome & Company | 223.32B |
| ISU Abxis | 219.48B |